Revealing on April 30: Are You Ready for the Upcoming Election Surprise?
Here is the latest financial fact sheet of PROCTER & GAMBLE HEALTH. For more details, see the PROCTER & GAMBLE HEALTH quarterly results and PROCTER & GAMBLE HEALTH share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.2 |
No. of shares | m | 16.60 |
1 Week | % | 1.1 |
1 Month | % | -0.7 |
1 Year | % | 1.0 |
52 week H/L | Rs | 5,640.0/4,595.9 |
No. of Mths Year Ending |
12 Dec-18* |
12 Jun-20* |
12 Jun-21* |
12 Jun-22* |
12 Jun-23* |
5-Yr Chart Click to enlarge
|
---|
PROCTER & GAMBLE HEALTH EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 3,549 | 5,121 | 7,500 | 5,850 | 5,366 | |
Low | Rs | 1,301 | 2,928 | 4,004 | 3,925 | 3,883 | |
Sales per share (Unadj.) | Rs | 511.4 | 816.8 | 607.7 | 671.3 | 740.7 | |
Earnings per share (Unadj.) | Rs | 61.3 | 153.1 | 106.5 | 116.0 | 138.2 | |
Diluted earnings per share | Rs | 61.3 | 153.1 | 106.5 | 116.0 | 138.2 | |
Cash flow per share (Unadj.) | Rs | 74.0 | 170.8 | 124.6 | 132.3 | 155.2 | |
Dividends per share (Unadj.) | Rs | 440.00 | 230.00 | 130.00 | 52.50 | 95.00 | |
Adj. dividends per share | Rs | 440.02 | 230.01 | 130.00 | 52.50 | 95.00 | |
Avg Dividend yield | % | 18.1 | 5.7 | 2.3 | 1.1 | 2.1 | |
Book value per share (Unadj.) | Rs | 927.8 | 544.8 | 421.6 | 367.0 | 447.6 | |
Adj. book value per share | Rs | 927.8 | 544.8 | 421.6 | 367.0 | 447.6 | |
Shares outstanding (eoy) | m | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 | |
Price / Sales ratio | x | 4.7 | 4.9 | 9.5 | 7.3 | 6.2 | |
Avg P/E ratio | x | 39.6 | 26.3 | 54.0 | 42.1 | 33.5 | |
P/CF ratio (eoy) | x | 32.8 | 23.6 | 46.2 | 36.9 | 29.8 | |
Price / Book Value ratio | x | 2.6 | 7.4 | 13.6 | 13.3 | 10.3 | |
Dividend payout | % | 717.9 | 150.3 | 122.1 | 45.3 | 68.7 | |
Avg Mkt Cap | Rs m | 40,256 | 66,801 | 95,477 | 81,132 | 76,761 | |
Total wages/salary | Rs m | 1,313 | 1,829 | 1,537 | 1,676 | 2,062 |
PROCTER & GAMBLE HEALTH INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 8,490 | 13,559 | 10,087 | 11,144 | 12,296 | |
Other income | Rs m | 284 | 700 | 181 | 132 | 184 | |
Total revenues | Rs m | 8,774 | 14,258 | 10,268 | 11,276 | 12,480 | |
Gross profit | Rs m | 1,507 | 3,143 | 2,460 | 2,677 | 3,247 | |
Depreciation | Rs m | 211 | 295 | 300 | 271 | 281 | |
Interest | Rs m | 0 | 0 | 8 | 4 | 8 | |
Profit before tax | Rs m | 1,580 | 3,549 | 2,333 | 2,534 | 3,142 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 562 | 1,008 | 565 | 609 | 847 | |
Profit after tax | Rs m | 1,017 | 2,541 | 1,768 | 1,925 | 2,295 | |
Gross profit margin | % | 17.8 | 23.2 | 24.4 | 24.0 | 26.4 | |
Effective tax rate | % | 35.6 | 28.4 | 24.2 | 24.0 | 27.0 | |
Net profit margin | % | 12.0 | 18.7 | 17.5 | 17.3 | 18.7 |
PROCTER & GAMBLE HEALTH BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 18,892 | 12,648 | 10,389 | 9,839 | 11,713 | |
Current liabilities | Rs m | 5,477 | 5,386 | 5,507 | 6,077 | 6,791 | |
Net working cap to sales | % | 158.0 | 53.6 | 48.4 | 33.8 | 40.0 | |
Current ratio | x | 3.4 | 2.3 | 1.9 | 1.6 | 1.7 | |
Inventory Days | Days | 246 | 195 | 288 | 263 | 263 | |
Debtors Days | Days | 284 | 256 | 216 | 273 | 343 | |
Net fixed assets | Rs m | 6,935 | 8,473 | 9,390 | 9,540 | 10,617 | |
Share capital | Rs m | 166 | 166 | 166 | 166 | 166 | |
"Free" reserves | Rs m | 15,235 | 8,878 | 6,832 | 5,926 | 7,265 | |
Net worth | Rs m | 15,401 | 9,044 | 6,998 | 6,092 | 7,431 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 25,826 | 21,121 | 19,778 | 19,379 | 22,330 | |
Interest coverage | x | 0 | 0 | 292.6 | 604.3 | 409.1 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.3 | 0.6 | 0.5 | 0.6 | 0.6 | |
Return on assets | % | 3.9 | 12.0 | 9.0 | 10.0 | 10.3 | |
Return on equity | % | 6.6 | 28.1 | 25.3 | 31.6 | 30.9 | |
Return on capital | % | 10.3 | 39.2 | 33.4 | 41.7 | 42.4 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 16.5 | 16.9 | 14.5 | 11.3 | 13.1 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 1,397 | 2,290 | 1,462 | 1,263 | 1,605 | |
Fx inflow | Rs m | 1,636 | 2,175 | 1,331 | 1,226 | 1,465 | |
Fx outflow | Rs m | 4,368 | 2,290 | 1,462 | 1,263 | 1,605 | |
Net fx | Rs m | -2,732 | -115 | -131 | -37 | -140 |
PROCTER & GAMBLE HEALTH CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -1,304 | 2,354 | 2,473 | 1,695 | 2,360 | |
From Investments | Rs m | 12,697 | 1,646 | -323 | -255 | -215 | |
From Financial Activity | Rs m | -301 | -8,834 | -3,866 | -2,886 | -985 | |
Net Cashflow | Rs m | 11,092 | -4,834 | -1,716 | -1,447 | 1,160 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Suresh N Talwar | COMP SEC: Preeti Bishnoi | YEAR OF INC: 1967 | BSE CODE: 500126 | FV (Rs): 10 | DIV YIELD (%): 2.0 |
Read: PROCTER & GAMBLE HEALTH 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB CIPLA ZYDUS LIFESCIENCES SUN PHARMA
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES DR. REDDYS LAB CIPLA ZYDUS LIFESCIENCES SUN PHARMA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.